Dyne Therapeutics Inc [NASDAQ: DYN] traded at a low on Tuesday, posting a -30.70 loss after which it closed the day’ session at $31.94.
The results of the trading session contributed to over 13723460 shares changing hands. Over the past one week, the price volatility of Dyne Therapeutics Inc stands at 11.35% while the volatility over the past one month is 6.92%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for DYN stock reached $3.21 billion, with 100.40 million shares outstanding and 74.33 million shares in the current float. Compared to the average trading volume of 1.02M shares, DYN reached a trading volume of 13723460 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Dyne Therapeutics Inc [DYN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DYN shares is $53.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DYN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for Dyne Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 21, 2024. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Overweight. The new note on the price target was released on April 30, 2024, representing the official price target for Dyne Therapeutics Inc stock. Previously, the target price had yet another raise to $36, while H.C. Wainwright analysts kept a Buy rating on DYN stock. On February 27, 2023, analysts increased their price target for DYN shares from 16 to 27.
The Average True Range (ATR) for Dyne Therapeutics Inc is set at 3.48 The Price to Book ratio for the last quarter was 4.13, with the Price to Cash per share for the same quarter was set at 7.76.
How has DYN stock performed recently?
Dyne Therapeutics Inc [DYN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -28.83. With this latest performance, DYN shares dropped by -21.77% in over the last four-week period, additionally plugging by 15.27% over the last 6 months – not to mention a rise of 180.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DYN stock in for the last two-week period is set at 26.86, with the RSI for the last a single of trading hit 19.46, and the three-weeks RSI is set at 33.20 for Dyne Therapeutics Inc [DYN]. The present Moving Average for the last 50 days of trading for this stock 41.45, while it was recorded at 42.47 for the last single week of trading, and 27.33 for the last 200 days.
Dyne Therapeutics Inc [DYN]: Deeper insight into the fundamentals
Dyne Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 26.63 and a Current Ratio set at 26.63.
Insider trade positions for Dyne Therapeutics Inc [DYN]
There are presently around $112.79%, or 113.24%% of DYN stock, in the hands of institutional investors. The top three institutional holders of DYN stocks are: ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with ownership of 8.02 million shares, which is approximately 9.8961%. FCPM III SERVICES B.V., holding 7.85 million shares of the stock with an approximate value of $$276.86 million in DYN stocks shares; and FCPM III SERVICES B.V., currently with $$260.69 million in DYN stock with ownership which is approximately 9.1148%.
